Posted in | News

RICS Honors Bristol National Composites Centre with Innovative Design Award

EPFL and Romande Energie inaugurate a façade cladded with novel photovoltaic panels conceived at the Solar Energy and Building Physics Laboratory (LESO-PB) under the direction of Andreas Schüler and developed at the EPFL Innovation Park by spin-off SwissINSO.

Members of the NCC team with their award

The coloured photovoltaic cladding on the new South façade of the EPFL ELL building marks a turning point in the architectural integration of solar cells and opens the door to a modern and attractive solar architecture.

A new patented surface treatment (Kromatix™) based on nanotechnology produces coloured glass for solar collectors with only a very small loss of efficiency. This technology - designed to meet the high esthetic requirements of architects and clients - adds a whole new range of colours to conventional thermal and photovoltaic pannels. The ELL façade is cladded with 105 m2 of photovoltaic panels that are expected to produce 10'000 kilowatthours a year.

The collectors installed on the ELL building are based on the following patent commercialised by the spin-off SwissINSO: WO 2014045141 A2: "Laminated glazing with coloured reflection and high solar transmittance suitable for solar energy systems", inventors Virginie le Caër and Andreas Schüler. ACOMET SA, Collombey and SOLSTIS SA, Lausanne - also a LESO-PB spin-off - were responsible for the installation and electric connection respectively .

The research group "Nanotechnology for Solar Energy Conversion", develops and characterizes novel nanostructured materials for solar energy applications. Due to their fascinating optical and electronical properties, nanometer-scaled structures play an important role in solar energy conversion.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.